MedAlliance SELUTION SLR receives second FDA IDE approval

Aug 10, 2022

Geneva [Switzerland], August 10 (ANI/PRNewswire): SELUTION SLR™, MedAlliance's novel sirolimus-eluting balloon, has received conditional FDA Investigational Device Exemption (IDE) approval to initiate its pivotal...

Excellent 12-month results from SELUTION SFA trial presented at JET

May 31, 2023

Geneva [Switzerland], May 31: 12-month results from the SELUTION SFA trial have been presented at the Japan Endovascular Treatment (JET) Conference in Tokyo. The...

Concept Medical's fourth IDE approval for the MagicTouch Sirolimus Coated Balloon is granted for the treatment of Superficial Femoral Artery Disease (SFA)

May 29, 2023

Tampa (Florida) [US], May 29: The US FDA, on the 24th of May 2023, granted an Investigational Device Exemption (IDE) approval for Concept Medical...

MedAlliance enrolls first US patient into its third FDA IDE Study: SFA SELUTION4SFA

May 05, 2023

Geneva [Switzerland], May 5 (ANI/PRNewswire): The first US patient has been enrolled in the SELUTION4SFA Sirolimus DEB study by Dr Arthur Lee at the...

FC Barcelona's Ansu Fati suffers femoral biceps injury

Jan 21, 2022

Barcelona [Spain], January 21 : FC Barcelona's Ansu Fati has a femoral biceps injury in his left thigh, the La Liga club confirmed on...

Is online dating effective or just superficial

Mar 08, 2021

Washington [US], March 8 : The findings of a study by Pew Research Center suggest that 1 out of 10 adults living in America...